441 related articles for article (PubMed ID: 34385999)
1. Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones.
Elst J; Maurer M; Sabato V; Faber MA; Bridts CH; Mertens C; Van Houdt M; Van Gasse AL; van der Poorten MM; De Puysseleyr LP; Hagendorens MM; Van Tendeloo VF; Lion E; Campillo-Davo D; Ebo DG
Front Immunol; 2021; 12():668962. PubMed ID: 34385999
[TBL] [Abstract][Full Text] [Related]
2. MRGPRX2 activation in mast cells by neuromuscular blocking agents and other agonists: Modulation by sugammadex.
Fernandopulle NA; Zhang SS; Soeding PF; Mackay GA
Clin Exp Allergy; 2021 May; 51(5):685-695. PubMed ID: 33275825
[TBL] [Abstract][Full Text] [Related]
3. MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia.
Navinés-Ferrer A; Serrano-Candelas E; Lafuente A; Muñoz-Cano R; Martín M; Gastaminza G
Sci Rep; 2018 Aug; 8(1):11628. PubMed ID: 30072729
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist.
Bawazir M; Amponnawarat A; Hui Y; Oskeritzian CA; Ali H
Front Immunol; 2022; 13():1033794. PubMed ID: 36275683
[TBL] [Abstract][Full Text] [Related]
5. Cisatracurium induces mast cell activation and pseudo-allergic reactions via MRGPRX2.
Che D; Rui L; Cao J; Wang J; Zhang Y; Ding Y; Zhao T; Ma P; An H; Gao Z; Zhang T
Int Immunopharmacol; 2018 Sep; 62():244-250. PubMed ID: 30032049
[TBL] [Abstract][Full Text] [Related]
6. MRGPRX2 and Adverse Drug Reactions.
McNeil BD
Front Immunol; 2021; 12():676354. PubMed ID: 34421893
[TBL] [Abstract][Full Text] [Related]
7. Mast cell-mediated hypersensitivity to fluoroquinolone is MRGPRX2 dependent.
Liu R; Hu S; Zhang Y; Che D; Cao J; Wang J; Zhao T; Jia Q; Wang N; Zhang T
Int Immunopharmacol; 2019 May; 70():417-427. PubMed ID: 30856392
[TBL] [Abstract][Full Text] [Related]
8. MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants.
Chompunud Na Ayudhya C; Amponnawarat A; Roy S; Oskeritzian CA; Ali H
Cells; 2021 Jan; 10(1):. PubMed ID: 33467419
[TBL] [Abstract][Full Text] [Related]
9. Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?
Spoerl D; Nigolian H; Czarnetzki C; Harr T
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590439
[TBL] [Abstract][Full Text] [Related]
10. Rocuronium Hypersensitivity: Does Off-Target Occupation of the MRGPRX2 Receptor Play a Role?
Van Gasse AL; Elst J; Bridts CH; Mertens C; Faber M; Hagendorens MM; De Clerck LS; Sabato V; Ebo DG
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):998-1003. PubMed ID: 30315997
[TBL] [Abstract][Full Text] [Related]
11. DOCK2 regulates MRGPRX2/B2-mediated mast cell degranulation and drug-induced anaphylaxis.
Kunimura K; Akiyoshi S; Uruno T; Matsubara K; Sakata D; Morino K; Hirotani K; Fukui Y
J Allergy Clin Immunol; 2023 Jun; 151(6):1585-1594.e9. PubMed ID: 36804596
[TBL] [Abstract][Full Text] [Related]
12. Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) in Drug Hypersensitivity Reactions.
Porebski G; Kwiecien K; Pawica M; Kwitniewski M
Front Immunol; 2018; 9():3027. PubMed ID: 30619367
[TBL] [Abstract][Full Text] [Related]
13. Revisiting the role of MRGPRX2 on hypersensitivity reactions to neuromuscular blocking drugs.
Ali H
Curr Opin Immunol; 2021 Oct; 72():65-71. PubMed ID: 33857758
[TBL] [Abstract][Full Text] [Related]
14. Typical antimicrobials induce mast cell degranulation and anaphylactoid reactions via MRGPRX2 and its murine homologue MRGPRB2.
Zhang T; Che D; Liu R; Han S; Wang N; Zhan Y; Pundir P; Cao J; Lv Y; Yang L; Wang J; Ding M; Dong X; He L
Eur J Immunol; 2017 Nov; 47(11):1949-1958. PubMed ID: 28688196
[TBL] [Abstract][Full Text] [Related]
15. Antibody or Anybody? Considering the Role of MRGPRX2 in Acute Drug-Induced Anaphylaxis and as a Therapeutic Target.
Mackay GA; Fernandopulle NA; Ding J; McComish J; Soeding PF
Front Immunol; 2021; 12():688930. PubMed ID: 34867939
[TBL] [Abstract][Full Text] [Related]
16. Identification of the dog orthologue of human MAS-related G protein coupled receptor X2 (MRGPRX2) essential for drug-induced pseudo-allergic reactions.
Hamamura-Yasuno E; Iguchi T; Kumagai K; Tsuchiya Y; Mori K
Sci Rep; 2020 Sep; 10(1):16146. PubMed ID: 32999394
[TBL] [Abstract][Full Text] [Related]
17. MRGPRX2 activation as a rapid, high-throughput mechanistic-based approach for detecting peptide-mediated human mast cell degranulation liabilities.
Lafleur MA; Werner J; Fort M; Lobenhofer EK; Balazs M; Goyos A
J Immunotoxicol; 2020 Dec; 17(1):110-121. PubMed ID: 32525431
[TBL] [Abstract][Full Text] [Related]
18. MRGPRX2 and Immediate Drug Hypersensitivity: Insights From Cultured Human Mast Cells.
Elst J; Sabato V; Faber MA; Bridts CH; Mertens C; Van Houdt M; Van Gasse AL; Hagendorens MM; Van Tendeloo V; Maurer M; Campillo-Davo D; Timmermans JP; Pintelon I; Ebo DG
J Investig Allergol Clin Immunol; 2021 Dec; 31(6):489-499. PubMed ID: 32732181
[TBL] [Abstract][Full Text] [Related]
19. MRGPRX2 is essential for sinomenine hydrochloride induced anaphylactoid reactions.
Liu R; Che D; Zhao T; Pundir P; Cao J; Lv Y; Wang J; Ma P; Fu J; Wang N; Wang X; Zhang T; Dong X; He L
Biochem Pharmacol; 2017 Dec; 146():214-223. PubMed ID: 28987593
[TBL] [Abstract][Full Text] [Related]
20. A novel MRGPRX2-targeting antagonistic DNA aptamer inhibits histamine release and prevents mast cell-mediated anaphylaxis.
Suzuki Y; Liu S; Ogasawara T; Sawasaki T; Takasaki Y; Yorozuya T; Mogi M
Eur J Pharmacol; 2020 Jul; 878():173104. PubMed ID: 32320700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]